TABLE 3

Characteristics of symptom dynamic phenotypes and reference phenotypes

Phenotype 1Phenotype 2Phenotype 3p-value
Dynamic (n=145)Reference (n=147)Dynamic (n=135)Reference (n=128)Dynamic (n=42)Reference (n=47)DynamicReference
Respiratory symptoms
 Weeks with severe symptoms0.22±0.430.14±0.370.82±1.030.87±0.982.11±1.642.14±1.53<0.001<0.001
 Weeks with any symptoms1.84±1.581.57±1.097.03±3.646.61±1.9612.19±3.5613.87±3.03<0.001<0.001
Respiratory symptoms transition states
 Entropy of transition states0.08±0.050.13±0.160.56±0.140.54±0.251.03±0.120.91±0.23<0.001<0.001
Risk factors
 Male sex50.343.549.656.364.365.90.2230.012
 Siblings37.238.157.153.966.772.4<0.001<0.001
 Caesarean section24.823.810.410.29.512.70.0020.008
 Maternal asthma9.68.89.610.216.717.10.3850.278
 Maternal atopy37.233.334.835.935.744.70.9140.370
 Childcare13.711.519.320.338.140.40.006<0.001
 Maternal smoking during pregnancy7.66.88.210.211.98.50.6680.606
 Parental smoking during infancy24.823.115.520.330.921.30.0510.805
 Breastfeeding ≤26 weeks21.420.421.523.423.821.30.9410.829
 Low maternal education64.161.962.264.159.561.70.8510.983
Season of birth
 Spring25.526.531.127.319.127.70.2640.983
 Summer22.118.427.435.933.321.30.2890.003
 Autumn35.835.416.315.614.317.1<0.001<0.001
 Winter16.519.725.221.133.334.10.0420.111
Outcomes at 6 year follow-up
 Any wheezing#27.622.428.938.364.351.1<0.001<0.001
 Current wheezing9.68.89.611.726.221.30.0080.071
 Atopic disease+35.436.337.139.446.336.20.4490.855
 SPT positive§13.314.512.313.119.413.20.5450.942

Data are presented as % or mean±sd. Symptom dynamic phenotypes were defined by the average entropy of transition states and reference phenotypes by weeks with any respiratory symptom. Differences in the distribution of characteristics across phenotypes were assessed using Chi-squared tests for categorical variables and Kruskal–Wallis tests for continuous variables. Significant p-values at the Bonferroni-corrected α-level of 0.017 are shown in bold. SPT: skin-prick test. #: defined as any wheezing episode between one and 6 years of age; : defined as wheezing over the past 12 months before follow-up; +: defined as allergic rhinitis, allergic asthma, or atopic dermatitis before follow-up; §: a SPT was completed in a subset of 270 children.